French Innovative Leukemia Organisation

OrganisationROR

Trials

  • NCT07624799

    Phase 2, Not yet recruiting, 82 people, 3 Jun 2026

  • NCT07007052

    Phase 2, Recruiting, 33 people, 5 Jun 2025

  • NCT04010968

    Phase 2, Completed, 120 people, 8 Jul 2019

  • NCT03766763

    Phase 2, Active, not recruiting, 82 people, 6 Dec 2018

  • NCT03734198

    Phase 2, Active, not recruiting, 29 people, 7 Nov 2018

  • NCT03609060

    Phase 2, Active, not recruiting, 120 people, 1 Aug 2018

  • NCT02962388

    Phase 2/3, Terminated, 13 people, 11 Nov 2016

  • NCT02666898

    Phase 2, Completed, 135 people, 28 Jan 2016

  • NCT01370772

    Phase 2, Completed, 140 people, 10 Jun 2011

  • NCT01074086

    Phase 1, Completed, 31 people, 24 Feb 2010

  • NCT00920153

    Phase 3, Terminated, 442 people, 15 Jun 2009

  • NCT00896519

    Phase 2, Status unknown, 30 people, 11 May 2009

  • NCT00842595

    Phase 2, Completed, 50 people, 12 Feb 2009

  • NCT00841945

    Phase 3, Terminated, 334 people, 12 Feb 2009

  • NCT00740415

    Phase 2, Completed, 39 people, 25 Aug 2008

  • NCT00700544

    Collaborator, Phase 3, Completed, 330 people, 18 Jun 2008

  • NCT00696735

    Phase 3, Completed, 172 people, 13 Jun 2008

  • NCT00600977

    Phase 2, Completed, 60 people, 25 Jan 2008

  • NCT00564512

    Phase 3, Completed, 178 people, 28 Nov 2007

  • NCT00536393

    Phase 2/3, Completed, 100 people, 27 Sept 2007